Literature DB >> 29167990

Histologic analysis has a prognostical value in colorectal biopsies assessed for suspicion of graft-versus-host disease.

Fanny Sauvestre1, Geneviève Belleannée2, Claire Bréal3, Catherine Mohr3, Harold IpKan Fong2, Sébastien Cossin4, Reza Tabrizi3, Noël Milpied3, Stéphane Vigouroux3, Jean-François Goussot2, Marion Marty2.   

Abstract

Gastrointestinal (GI) graft-versus-host-disease (GVHD) is a common and severe complication of allogeneic hematopoietic stem cell transplantation, but clinical and histological features are unspecific. The aim of this study was to correlate the histological GI GVHD grade with the clinical outcomes. In a retrospective study of 112 patients with clinically suspected GI GVHD, colonic biopsies were reviewed by three pathologists without knowledge of the corresponding clinical data and classified in four scores, according to the NIH Consensus Project recommendations: no GVHD, possible, probable, and unequivocal GVHD. At the end of the study, the histological and clinical data were confronted with the following results: clinical diagnosis of GI GVHD was established for 70 patients (62.5%) and histological scores correlated well with the clinical diagnosis (p < 0.001) and particularly with the prognosis (p < 0.05).When severe lesions were observed, the 1 year overall survival declined to 9%. None of the features reported in the literature to support GVHD diagnosis, eosinophil count, endocrine cells aggregate, immunohistochemical analysis (cytomegalovirus, CD123, chromogranin), did not help us for diagnosis. So routine histopathology alone without immunohistochemistry is a strong and reproducible tool to diagnose GI GVHD with the help of clinical and biological information, and most importantly, histological grading proved to be a powerful prognostic value.

Entities:  

Keywords:  Apoptosis; Colon; Graft-versus host disease; Mycophenolate mofetil; Stem cell transplantation

Mesh:

Year:  2017        PMID: 29167990     DOI: 10.1007/s00428-017-2272-2

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  21 in total

1.  NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.

Authors:  Howard M Shulman; Diana M Cardona; Joel K Greenson; Sangeeta Hingorani; Thomas Horn; Elisabeth Huber; Andreas Kreft; Thomas Longerich; Thomas Morton; David Myerson; Victor G Prieto; Avi Rosenberg; Nathaniel Treister; Kay Washington; Mirjana Ziemer; Steven Z Pavletic; Stephanie J Lee; Mary E D Flowers; Kirk R Schultz; Madan Jagasia; Paul J Martin; Georgia B Vogelsang; David E Kleiner
Journal:  Biol Blood Marrow Transplant       Date:  2015-01-29       Impact factor: 5.742

2.  Gastric graft-versus-host disease: a blinded histologic study.

Authors:  K Washington; R C Bentley; A Green; J Olson; W R Treem; H R Krigman
Journal:  Am J Surg Pathol       Date:  1997-09       Impact factor: 6.394

3.  Improved survival after allogeneic hematopoietic stem cell transplantation in recent years. A single-center study.

Authors:  Mats Remberger; Malin Ackefors; Sofia Berglund; Ola Blennow; Göran Dahllöf; Aldona Dlugosz; Karin Garming-Legert; Jens Gertow; Britt Gustafsson; Moustapha Hassan; Zuzana Hassan; Dan Hauzenberger; Hans Hägglund; Helen Karlsson; Lena Klingspor; Gunilla Kumlien; Katarina Le Blanc; Per Ljungman; Maciej Machaczka; Karl-Johan Malmberg; Hanns-Ulrich Marschall; Jonas Mattsson; Richard Olsson; Brigitta Omazic; Darius Sairafi; Marie Schaffer; Britt-Marie Svahn; Petter Svenberg; Lisa Swartling; Attila Szakos; Michael Uhlin; Mehmet Uzunel; Emma Watz; Annika Wernerson; Agneta Wikman; Ann-Charlotte Wikström; Jacek Winiarski; Olle Ringdén
Journal:  Biol Blood Marrow Transplant       Date:  2011-05-11       Impact factor: 5.742

Review 4.  Colonic graft-versus-host disease.

Authors:  William A Ross; Daniel Couriel
Journal:  Curr Opin Gastroenterol       Date:  2005-01       Impact factor: 3.287

5.  The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: a prospective study of thirteen patients.

Authors:  R J Epstein; G B McDonald; G E Sale; H M Shulman; E D Thomas
Journal:  Gastroenterology       Date:  1980-04       Impact factor: 22.682

6.  Histological features of skin and rectal biopsy specimens after autologous and allogeneic bone marrow transplantation.

Authors:  L Sviland; A D Pearson; E J Eastham; P J Hamilton; S J Proctor; A J Malcolm
Journal:  J Clin Pathol       Date:  1988-02       Impact factor: 3.411

7.  A histopathologic study of gastric and small intestinal graft-versus-host disease following allogeneic bone marrow transplantation.

Authors:  D C Snover; S A Weisdorf; G M Vercellotti; B Rank; S Hutton; P McGlave
Journal:  Hum Pathol       Date:  1985-04       Impact factor: 3.466

8.  Histologic features of mycophenolate mofetil-related colitis: a graft-versus-host disease-like pattern.

Authors:  John C Papadimitriou; Charles B Cangro; Alexander Lustberg; Amr Khaled; Joseph Nogueira; Ann Wiland; Emilio Ramos; David K Klassen; Cinthia B Drachenberg
Journal:  Int J Surg Pathol       Date:  2003-10       Impact factor: 1.271

Review 9.  Pathology of graft-versus-host disease in the gastrointestinal tract.

Authors:  Kay Washington; Madan Jagasia
Journal:  Hum Pathol       Date:  2009-07       Impact factor: 3.466

10.  Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation.

Authors:  C Castilla-Llorente; P J Martin; G B McDonald; B E Storer; F R Appelbaum; H J Deeg; M Mielcarek; H Shulman; R Storb; R A Nash
Journal:  Bone Marrow Transplant       Date:  2014-04-28       Impact factor: 5.483

View more
  1 in total

1.  An investigation of the diagnostic, predictive, and prognostic impacts of three colonic biopsy grading systems for acute graft versus host disease.

Authors:  Andreas Kreft; Katrin Hippe; Eva Maria Wagner-Drouet; Isabelle Ries; Arne Kandulski; Maike Büttner-Herold; Helmut Neumann; Daniela Weber; Ernst Holler; Mario Schindeldecker
Journal:  PLoS One       Date:  2021-08-26       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.